I believe CEMJQ will continue to trade until they exit BK and a new stock under a new ticker on an uplisted exchange begins trading (possibly CEM again). What it will be trading for when they come out will depend on what terms are in the POR. I think the #1 question on this board post-POR will be "what will the value be of the new stock"? Assuming equity recovery, it'll likely be a lot higher than 1.25 by the time of the uplist. And if Visteon is any guide, it could trade above 1.25 again even if management shuts out equity, if investors feel the court won't approve the plan as is.
BTW, the fact that the EC did not vehemently oppose the debtors exclusivity extension (which bars the EC from entering a
competing plan until September) is either a good sign, a smart legal strategy to not piss off the company and the judge, or both.
They did make stipulations that their approval is contingent on adequate recovery.